Sfoglia per Autore
Adjuvant intravesical therapy in intermediate risk non-muscle invasive bladder cancer (NMIBC) recurring after first cycle of intravesical treatment.
2011-01-01 Serretta, V; Allegro, R; Somatino, F; Scaduto, G; Daricello, M; Melloni, D
SMOKING STATUS, RECURRENCE RISK AND INTRAVESICAL CHEMOTHERAPY IN NONMUSCLE- INVASIVE BLADDER CANCER
2011-01-01 Serretta, V; Morgia, G; Altieri, V; Carrieri, G; Di Lallo, A; Allegro, R
Re-treatment by intravesical therapy in recurring patients affected by intermediate risk non-muscle invasive bladder cancer (NMIBC)
2011-01-01 Serretta, V; Sommatino, F; Billone, V; Daricello, M; Allegro, R; Melloni, D
The multicriteria Electre III model applied to the evaluation of the placement of university graduates
2011-01-01 Allegro, R; Giambalvo, O
CHOICE OF ADJUVANT INTRAVESICAL THERAPY IN RECURRING INTERMEDIATE-RISK NMI-BC
2011-01-01 Serretta, V; Sommatino, F; Romeo, S; Territo, A; Allegro, R; Melloni, D
The genitourinary diseases health-care among patients and general practitioner
2012-01-01 Serretta, V; Sommatino, F; Romeo, S; Alonge, V; Caruana, G; Dispensa, N; Allegro, R; Pavone, C
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
2012-01-01 Serretta, V; Altieri, V; Morgia, G.; Nicolosi, F.; De Grande, G.; Mazza, R.; Melloni, D.; Allegro, R.; Ferraù, F.; Gebbia, V.
Cigarette Smoking Status at Diagnosis and Recurrence in Intermediate-risk Nonemuscle-invasive Bladder Carcinoma
2013-01-01 Serretta, V; Altieri, V; Morgia, G; Di Lallo, A; Carrieri, G; Allegro, R
UROTHELIAL EGF-R GENE EXPRESSION IN BLADDER WASHINGS: A FEASIBILITY STUDY
2015-01-01 Serretta, V.; Scalici Gesolfo, C.; Di Maida, F.; Cangemi, A.; Caruso, S.; Russo, A.; Allegro, R.
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY
2015-01-01 Alonge, V.; Scalici Gesolfo, C.; Di Maida, F.; Cicero, G.; Cangemi, A.; Russo, A.; D’Arienzo, M.; Allegro, R.; Serretta, V.
THE ROLE OF INTRAVESICAL GLYCOSAMINOGLYCANS IN TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY: GENETIC LABORATORY EVIDENCE
2015-04-01 Serretta, V.; Alonge, V.; Scalici Gesolfo, C.; Tulone, G.; Cangemi, A.; Caruso, S.; Russo, A.; D'Arienzo, M.; Allegro, R.
VISCERAL FAT TISSUE ACTIVITY DOES NOT CORRELATE TO HIGH GRADE PROSTATE CANCER RISK AT BIOPSY
2015-06-01 Scurria, S.; Siracusano, S.; Giacalone, N.; Cangemi, A.; Caruso, S.; Allegro, R.; Russo, A.; Colombo, R.; Serretta, V.
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression
2019-01-01 Di Maida, Fabrizio; Mari, Andrea; Scalici Gesolfo, Cristina; Cangemi, Antonina; Allegro, Rosalinda; Sforza, Simone; Cocci, Andrea; Tellini, Riccardo; Masieri, Lorenzo; Russo, Antonio; Carini, Marco; Minervini, Andrea; Serretta, Vincenzo
University Performance Before and During Economic Crises. An Analysis of Graduate Characteristics
2020-01-01 Allegro, R, Giambalvo, O
Medial tunica degeneration of the ascending aortic wall is associated with specific microRNA changes in bicuspid aortic valve disease
2021-12-01 Pisano, C; Marino Gammazza, A; Rappa, F; Barone, R; Allegro, R; Pitruzzella, A; Tagliavia, A; Agostara, V; Ruvolo, G; Cappello, F; Argano, V
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile